RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+15.53%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$1.32B
AUM Growth
+$1.32B
(+7.1%)
Cap. Flow
+$23.1M
Cap. Flow
% of AUM
1.76%
Top 10 Holdings %
Top 10 Hldgs %
27.59%
Holding
136
New
16
Increased
50
Reduced
27
Closed
17
Top Buys
Top Sells
| 1 |
AbbVie
ABBV
|
$39M |
| 2 |
STJ
St Jude Medical
STJ
|
$33.4M |
| 3 |
TMH
Team Health Holdings Inc
TMH
|
$17M |
| 4 |
ADPT
Adeptus Health Inc.
ADPT
|
$14.4M |
| 5 |
TRNX
TORNIER N V SHARES (NLD)
TRNX
|
$13.5M |
Sector Composition
| 1 | Healthcare | 77.12% |
| 2 | Financials | 3.37% |
| 3 | Industrials | 0.48% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
1
DELISTED
Allergan plc
AGN
| $50.6M | 3.84% | 162,000 +36,000 | +29% | +$11.3M |
|
|
AET
2
DELISTED
Aetna Inc
AET
| $44.4M | 3.37% | 411,000 +25,000 | +6% | +$2.7M |
|
3
Acadia Healthcare
ACHC
$2.12B
| $42.2M | 3.19% | 675,000 -137,000 | -17% | -$8.56M |
|
|
ALXN
4
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $36.8M | 2.79% | 193,000 +21,000 | +12% | +$4.01M |
|
|
RDUS
5
DELISTED
Radius Health, Inc.
RDUS
| $36.8M | 2.79% | 597,500 +37,500 | +7% | +$2.31M |
|
6
Gilead Sciences
GILD
$140B
| $32.9M | 2.49% | 325,300 +67,800 | +26% | +$6.86M |
|
|
BXLT
7
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| $31.6M | 2.4% | +810,000 | New | +$31.6M |
|
8
Pfizer
PFE
$141B
| $31.5M | 2.38% | 975,000 +215,000 | +28% | +$6.94M |
|
9
HCA Healthcare
HCA
$94.5B
| $29.1M | 2.2% | 430,000 -60,500 | -12% | -$4.09M |
|
10
Collegium Pharmaceutical
COLL
$1.22B
| $27.7M | 2.1% | 1,005,487 +11,087 | +1% | +$305K |
|
|
CELG
11
DELISTED
Celgene Corp
CELG
| $27.5M | 2.09% | 230,000 +32,000 | +16% | +$3.83M |
|
|
ONCE
12
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $25.4M | 1.92% | 560,000 +60,000 | +12% | +$2.72M |
|
|
AAAP
13
DELISTED
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
| $25M | 1.9% | +800,000 | New | +$25M |
|
14
Teva Pharmaceuticals
TEVA
$21.1B
| $24.9M | 1.89% | 379,300 +54,300 | +17% | +$3.56M |
|
15
Aclaris Therapeutics
ACRS
$209M
| $24.1M | 1.83% | +896,154 | New | +$24.1M |
|
|
MDCO
16
DELISTED
Medicines Co
MDCO
| $23.3M | 1.77% | 625,000 +30,000 | +5% | +$1.12M |
|
17
Eli Lilly
LLY
$657B
| $23.2M | 1.76% | 275,897 +43,397 | +19% | +$3.66M |
|
18
Intuitive Surgical
ISRG
$170B
| $21.6M | 1.63% | 39,500 +3,500 | +10% | +$1.91M |
|
19
Neurocrine Biosciences
NBIX
$13.8B
| $21.4M | 1.62% | 377,500 +3,500 | +0.9% | +$198K |
|
20
Pacira BioSciences
PCRX
$1.2B
| $20M | 1.51% | 260,000 +92,000 | +55% | +$7.06M |
|
21
Cigna
CI
$80.3B
| $17.9M | 1.35% | 122,000 | – | – |
|
|
TSRO
22
DELISTED
TESARO, Inc.
TSRO
| $17.5M | 1.32% | 334,000 +108,000 | +48% | +$5.65M |
|
23
Prothena Corp
PRTA
$441M
| $16.9M | 1.28% | 248,000 | – | – |
|
24
Elevance Health
ELV
$71.8B
| $16.8M | 1.28% | 120,800 +33,300 | +38% | +$4.64M |
|
|
WCG
25
DELISTED
Wellcare Health Plans, Inc.
WCG
| $16.8M | 1.27% | +214,500 | New | +$16.8M |
|